Kao C H, Hsieh K S, Wang Y L, Chen C W, Liao S Q, Wang S J, Yeh S H
Department of Nuclear Medicine, Taichung, Veterans General Hospital, Taiwan, Republic of China.
Clin Nucl Med. 1992 Aug;17(8):623-6. doi: 10.1097/00003072-199208000-00002.
Eighteen patients with Kawasaki disease and suspected carditis (11 boys, 7 girls, mean age 18 months) in acute stages underwent Tc-99m HMPAO WBC imaging of the heart. Signs and symptoms subsided after conventional aspirin therapy and the intravenous injection of high-dose (400 mg/kg per day for 5 days) gamma-globulin treatments. Tc-99m HMPAO WBC imaging of the heart was arranged a second time to evaluate the effects of the treatments for carditis. The results showed that a significant difference existed in the severity of carditis before and after the treatments (P less than 0.001, by signed rank test), 39% (7/18) with significant improvement in severity of carditis, 50% (9/18) without definite change. However, 11% (2/18) became more severely ill after the treatments. Tc-99m HMPAO WBC imaging may be useful in detecting carditis in Kawasaki disease and in evaluating the effects of aspirin plus the newly recommended gamma-globulin for the treatment of carditis in Kawasaki disease.
18例处于急性期的川崎病合并疑似心肌炎患儿(男11例,女7例,平均年龄18个月)接受了心脏99m锝-六甲基丙二胺肟白细胞显像检查。经传统阿司匹林治疗及静脉注射大剂量(400mg/kg每日,共5日)丙种球蛋白后,症状体征消退。再次安排心脏99m锝-六甲基丙二胺肟白细胞显像检查以评估心肌炎治疗效果。结果显示,治疗前后心肌炎严重程度存在显著差异(经符号秩检验,P<0.001),39%(7/18)心肌炎严重程度显著改善,50%(9/18)无明显变化。然而,11%(2/18)治疗后病情加重。99m锝-六甲基丙二胺肟白细胞显像可能有助于检测川崎病中的心肌炎,并评估阿司匹林联合新推荐的丙种球蛋白治疗川崎病心肌炎的效果。